CAGW urges the U.S. Department of Health & Human Services to not steal Gilead’s patent, which was requested by state attorney generals.
CCAGW Letter to Mark Meadows Opposing Foreign Drug Pricing
July 20, 2020 The Honorable Mark Meadows Chief of Staff The White House Washington, D.C. 20500 Dear Chief of Staff Meadows,
CCAGW Urges Opposition to H.R. 1957
CCAGW sends a letter to the House opposing H.R. 1957 the Great American Outdoors Act, as amended by the Senate.
CCAGW Joins Coalition Supporting the CREATE JOBS Act
The CREATE JOBS Act would accelerate America’s economic recovery from the COVID-19 pandemic, and should be included in any relief or recovery package passed by Congress in the near future.
CCAGW Joins Coalition Concerned about the SCRIPTS Act
July 14, 2020 RE: Stopping Censorship, Restoring Integrity, and Protecting Talkies Act, SCRIPT Act, S. 3835 Dear Senators:
CCAGW Objects to Record-setting Earmarks
CCAGW sends a letter to the House objecting to record-setting earmarks in H.R. 7608. Earmarks include $20 million for The Asia Foundation and $19.7 million for the East-West Center.
CAGW Supports a Consistent Cost-Benefit Analysis for the Clean Air Act
The EPA must ensure that the Clean Air Act rules proposed under the Advance Notice of Proposed Rulemaking must provide consistent and high quality cost-benefit analyses for significant rules.
Coalition Opposes Extension of UC Benefits
Coalition opposes the extension of expanded unemployment compensation.
CCAGW Urges D.C. Councilmembers to Vote Against Unnecessary and Harmful Taxes
CCAGW urges councilmembers to vote against taxes that would affect consumers, businesses, and taxpayers in the District of Columbia
CAGW urges White House to Withdraw Proposed EOs regarding Foreign Reference Drug Pricing
CAGW asks the White House Chief of Staff to withdraw any proposed Executive Orders regarding foreign drug pricing.